Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153635165> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2153635165 endingPage "S180" @default.
- W2153635165 startingPage "S180" @default.
- W2153635165 abstract "To determine the relationship between tumor control probability (TCP) and average biological effective dose (aBED) for dose-escalated 3D Conformal (3D-CRT) and stereotactic body radiation therapy (SBRT) in medically inoperable stage I Non-Small Cell Lung Cancer (NSCLC). Forty-two original prospective or retrospective studies on 3D-CRT and SBRT for Stage I NSCLC were reviewed (published from July 1988 - March 2010) in the context of tumor control (TC) - defined as crude local control ≥ 2 years, as a function of aBED. Only studies with at least 2-year TC data were included. For a given dose-fractionation schedule, aBED was calculated at isocenter using the linear quadratic formula: BED = d [1+(d/n)/(α/β)], assuming an α/β ratio of 10 (n = number of fractions, d = total dose). A scatter plot of TC versus aBED for each included study was generated and fitted to the standard TCP equation by the least-squares method: TCP = exp ([d - TCD50]/k) / [1+exp([d - TCD50]/k)]. Daily fraction size ≥ 6 Gy was considered SBRT. Two thousand six hundred ninety-six patients were included in this study (SBRT:1640; 3D-CRT:1056). Median patient age was 73 (22-95). By histology, 704 tumors were adenocarcinoma, 847 squamous cell carcinoma, and 1145 were not otherwise specified. Daily fraction size was 1.2 - 4 Gy (total dose: 48-102.9) for patients treated with 3D-CRT and 6 - 26 Gy (total dose: 20-66) for patients treated with SBRT. Median aBED was 105.6 Gy (range 59.6-286.6). aBED to achieve 50% TC (TCD50) was 60.6 Gy (95% CI, 50.2-71.1) and the slope50, defined as 25/k, was 0.73%/Gy (95% CI, 0.47-1.0), r = 0.87. TCP as a function of aBED was sigmoidal, with the following values (TCP range, aBED range): (42-60%, 50-75 Gy); (61-76%, 76-100 Gy); (76-87%, 101-125 Gy); (87-93%, 126-150 Gy); (93-96%, 151-175 Gy); (97-98%, 176-200 Gy); and (≥ 98%, > 200 Gy). This is the largest meta-analysis to model TCP as a function of aBED for curative radiotherapy in stage I NSCLC. Near the plateau of the sigmoidal curve, the predicted TCP is ≥ 90% for aBED ≥ 135 Gy. Dose-escalation beyond this aBED likely translates into clinically insignificant gain in the TCP but may result in the addition of clinically significant toxicity. When delivered with SBRT, aBED of 135 Gy corresponds to a total dose of 50 Gy in 3 fractions at the isocenter. Analysis of additional predictive variables for TC for curative radiotherapy in stage I NSCLC is underway." @default.
- W2153635165 created "2016-06-24" @default.
- W2153635165 creator A5006141000 @default.
- W2153635165 creator A5011937309 @default.
- W2153635165 creator A5064969499 @default.
- W2153635165 creator A5069103074 @default.
- W2153635165 creator A5075740763 @default.
- W2153635165 creator A5084336940 @default.
- W2153635165 date "2010-11-01" @default.
- W2153635165 modified "2023-09-27" @default.
- W2153635165 title "Curative Radiotherapy for Stage I Non-small Cell Lung Cancer: Is There Evidence for Further Dose Escalation?" @default.
- W2153635165 doi "https://doi.org/10.1016/j.ijrobp.2010.07.439" @default.
- W2153635165 hasPublicationYear "2010" @default.
- W2153635165 type Work @default.
- W2153635165 sameAs 2153635165 @default.
- W2153635165 citedByCount "2" @default.
- W2153635165 countsByYear W21536351652016 @default.
- W2153635165 countsByYear W21536351652017 @default.
- W2153635165 crossrefType "journal-article" @default.
- W2153635165 hasAuthorship W2153635165A5006141000 @default.
- W2153635165 hasAuthorship W2153635165A5011937309 @default.
- W2153635165 hasAuthorship W2153635165A5064969499 @default.
- W2153635165 hasAuthorship W2153635165A5069103074 @default.
- W2153635165 hasAuthorship W2153635165A5075740763 @default.
- W2153635165 hasAuthorship W2153635165A5084336940 @default.
- W2153635165 hasBestOaLocation W21536351651 @default.
- W2153635165 hasConcept C121608353 @default.
- W2153635165 hasConcept C126322002 @default.
- W2153635165 hasConcept C146357865 @default.
- W2153635165 hasConcept C151730666 @default.
- W2153635165 hasConcept C181401712 @default.
- W2153635165 hasConcept C2776256026 @default.
- W2153635165 hasConcept C2779343474 @default.
- W2153635165 hasConcept C2781182431 @default.
- W2153635165 hasConcept C2989005 @default.
- W2153635165 hasConcept C509974204 @default.
- W2153635165 hasConcept C71924100 @default.
- W2153635165 hasConcept C86803240 @default.
- W2153635165 hasConceptScore W2153635165C121608353 @default.
- W2153635165 hasConceptScore W2153635165C126322002 @default.
- W2153635165 hasConceptScore W2153635165C146357865 @default.
- W2153635165 hasConceptScore W2153635165C151730666 @default.
- W2153635165 hasConceptScore W2153635165C181401712 @default.
- W2153635165 hasConceptScore W2153635165C2776256026 @default.
- W2153635165 hasConceptScore W2153635165C2779343474 @default.
- W2153635165 hasConceptScore W2153635165C2781182431 @default.
- W2153635165 hasConceptScore W2153635165C2989005 @default.
- W2153635165 hasConceptScore W2153635165C509974204 @default.
- W2153635165 hasConceptScore W2153635165C71924100 @default.
- W2153635165 hasConceptScore W2153635165C86803240 @default.
- W2153635165 hasIssue "3" @default.
- W2153635165 hasLocation W21536351651 @default.
- W2153635165 hasOpenAccess W2153635165 @default.
- W2153635165 hasPrimaryLocation W21536351651 @default.
- W2153635165 hasRelatedWork W2037819752 @default.
- W2153635165 hasRelatedWork W2147367600 @default.
- W2153635165 hasRelatedWork W2277416945 @default.
- W2153635165 hasRelatedWork W2388931413 @default.
- W2153635165 hasRelatedWork W2389744545 @default.
- W2153635165 hasRelatedWork W2400217987 @default.
- W2153635165 hasRelatedWork W2406962104 @default.
- W2153635165 hasRelatedWork W2465910797 @default.
- W2153635165 hasRelatedWork W3185463017 @default.
- W2153635165 hasRelatedWork W4282836056 @default.
- W2153635165 hasVolume "78" @default.
- W2153635165 isParatext "false" @default.
- W2153635165 isRetracted "false" @default.
- W2153635165 magId "2153635165" @default.
- W2153635165 workType "article" @default.